课题基金 / 基金详情

Host-Pathogen Interactions in the Mammalian Airway

Host-Pathogen Interactions in the Mammalian Airway
哺乳动物气道中宿主与病原体的相互作用
批准号:
6727492
负责人:
GILL DIAMOND
金额:
$31.1万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2007-03-31

项目摘要

项目成果

GILL DIAMOND的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):哺乳动物气管内的上皮细胞是宿主防御空气中微生物病原体的关键部位,可释放大量抗菌因子。这些防御的缺陷可能导致反复的气道感染。这些防御机制之一是诱导β -防御素的产生,β -防御素是哺乳动物上皮细胞中高度丰富的一类同源抗生素肽。编码β -防御素的基因在呼吸上皮中高水平表达,并由细菌产物和炎症介质诱导。初步和已发表的数据支持这样的假设,即一些致病菌株可以通过抑制β -防御素基因表达来逃避气道内的先天免疫系统,从而减少气道的抗菌防御。特定的细菌毒力因子允许逃避宿主第一道防线并定植气道的机制尚未确定。阐明这些机制将有助于制定气道感染的治疗策略。我们研究的长期目标是更好地了解气道中动态宿主防御系统。在这个建议中,我们关注气道病原体,支气管脓杆菌与其在呼吸道上皮中的靶细胞的相互作用。结核分枝杆菌与动物的呼吸道感染有关,并与人类百日咳的病原体百日咳密切相关。我们假设气道上皮细胞通过特定受体识别分子模式对细菌做出反应,从而激活NF-kappaB并诱导β -防御素基因表达,以防止定植。病原菌可以通过干扰先天免疫应答的III型分泌因子干扰抗菌肽基因的上调,从而阻止抗菌肽的增加。为了验证这些假设,提出以下目标:1。定义结核分枝杆菌与气道上皮细胞的相互作用以及由此产生的先天免疫反应的诱导。2. 明确强毒分枝杆菌抑制先天免疫诱导的机制。这些研究的目的是确定气道上皮如何通过启动宿主防御反应来响应这种模型病原体。第二个目标将确定细菌如何利用蛋白质组学来确定负责这一作用的细菌因子,以及该因子与防御反应相互作用的综合表征。这些信息将为开发用于呼吸道的新疗法奠定基础。这将包括调节内源性抗菌肽表达以预防严重细菌感染的策略。
英文摘要
DESCRIPTION (provided by applicant): Epithelial cells lining the mammalian trachea form a crucial site in the host defense against airborne microbial pathogens, releasing numerous antimicrobial factors. Deficiencies in these defenses may result in recurrent airway infections. One of these defense mechanisms is the inducible production of beta-defensins, a class of homologous antibiotic peptides highly abundant in mammalian epithelial cells. The genes encoding beta-defensins are expressed at high levels in the respiratory epithelium, and are induced by bacterial products and inflammatory mediators. Preliminary and published data support the hypothesis that some pathogenic strains of bacteria can evade the innate immune system in the airway by inhibiting beta-defensin gene expression, which can in turn diminish the antimicrobial defense of the airway. The mechanisms by which the specific bacterial virulence factors allow evasion of the first lines of host defense to colonize the airway are not yet defined. Elucidation of these mechanisms will aid in the development of therapeutic strategies for airway infections. The long-range goal of our research is to better understand the dynamic host defense systems in the airway. In this proposal we focus on the interactions of the airway pathogen, Bordetella bronchiseptica with its target cells in the respiratory epithelium. B. bronchiseptica is associated with respiratory infections in animals, and is closely related to B. pertussis, the causative agent of whooping cough in humans. We hypothesize that airway epithelial cells respond to bacteria by recognition of molecular patterns by specific receptors, resulting in the activation of NF-kappaB and induction of beta-defensin gene expression in order to prevent colonization. Pathogenic strains of B. bronchiseptica can prevent the increased production of antimicrobial peptides by interfering with the upregulation of the antimicrobial peptide genes through a type III secretion factor which interferes with the innate immune response. To test these hypotheses, the following aims are proposed: 1. Define the interaction of B. bronchiseptica with airway epithelial cells and the resultant induction of an innate immune response. 2. Define the mechanism of inhibition of innate immune induction by virulent B. bronchiseptica. The objective of these studies is to define how the airway epithelium responds to this model pathogen by the initiation of a host defense response. The second aim will determine how the bacterium circumvents this response utilizing proteomics to identify the bacterial factor responsible for this action, as well as a comprehensive characterization of the interaction of this factor and the defense response. The information will serve as a foundation for the development of novel therapies designed to work in the respiratory tract. This would include strategies to modulate the endogenous antimicrobial peptide expression to prevent serious bacterial infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Initiation of immune responses to SARS COV2 in the oral cavity and upper airway
  • 批准号:
    10990201
  • 项目类别:
  • 资助金额:
    $76.44万
  • 财政年份:
    2023
  • 负责人:
    GILL DIAMOND
  • 依托单位:
Initiation of immune responses to SARS COV2 in the oral cavity and upper airway
Initiation of immune responses to SARS COV2 in the oral cavity and upper airway
Antimicrobial peptide mimetic activity against Candida auris
  • 批准号:
    10369013
  • 项目类别:
  • 资助金额:
    $23.04万
  • 财政年份:
    2021
  • 负责人:
    GILL DIAMOND
  • 依托单位:
海外基金